Outcome Heterogeneity in Coronavirus Disease 2019 (COVID-19) Patients Receiving Tocilizumab

被引：1

作者：

Niu, Man Man ^{[1
]}

Cao, Yue ^{[1
]}

Li, Rui Xue ^{[1
]}

Fan, Guo Zhen ^{[1
]}

Hu, Peng ^{[1
]}

机构：

[1] Anhui Med Univ, Affiliated Hosp 1, Dept Pediat, 218 Ji Xi Rd, Hefei 230022, Anhui, Peoples R China

来源：

CLINICAL INFECTIOUS DISEASES | 2022年 / 74卷 / 08期

关键词：

D O I：

10.1093/cid/ciab816

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1504 / 1504

页数：1

共 8 条

[1] Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis [J].

Chen, Xinhua ;

Chen, Zhiyuan ;

Azman, Andrew S. ;

Sun, Ruijia ;

Lu, Wanying ;

Zheng, Nan ;

Zhou, Jiaxin ;

Wu, Qianhui ;

Deng, Xiaowei ;

Zhao, Zeyao ;

Chen, Xinghui ;

Ge, Shijia ;

Yang, Juan ;

Leung, Daniel T. ;

Yu, Hongjie .

CLINICAL INFECTIOUS DISEASES, 2022, 74 (04) :734-742

[2]

Gordon AC, 2021, NEW ENGL J MED, V384, P1491, DOI [10.1056/NEJMc2108482, 10.1056/NEJMoa2100433]

[3] Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses [J].

Jostock, T ;

Müllberg, J ;

Özbek, S ;

Atreya, R ;

Blinn, G ;

Voltz, N ;

Fischer, M ;

Neurath, MF ;

Rose-John, S .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (01) :160-167

[4] Decreased Mortality in Coronavirus Disease 2019 Patients Treated With Tocilizumab: A Rapid Systematic Review and Meta-analysis of Observational Studies [J].

Malgie, Jishnu ;

Schoones, Jan W. ;

Pijls, Bart G. .

CLINICAL INFECTIOUS DISEASES, 2021, 72 (11) :E742-E749

[5] Compiling Observational Research During a Pandemic: A Necessary Bridge [J].

Moehring, Rebekah W. ;

Holland, Thomas L. .

CLINICAL INFECTIOUS DISEASES, 2021, 72 (11) :E750-E752

[6] Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta) [J].

Ong, Sean Wei Xiang ;

Chiew, Calvin J. ;

Ang, Li Wei ;

Mak, Tze-Minn ;

Cui, Lin ;

Toh, Matthias Paul H. S. ;

Lim, Yi Ding ;

Lee, Pei Hua ;

Lee, Tau Hong ;

Chia, Po Ying ;

Maurer-Stroh, Sebastian ;

Lin, Raymond T. P. ;

Leo, Yee-Sin ;

Lee, Vernon J. ;

Lye, David Chien ;

Young, Barnaby Edward .

CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) :E1128-E1136

[7] Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis [J].

Tleyjeh, Imad M. ;

Kashour, Zakariya ;

Damlaj, Moussab ;

Riaz, Muhammad ;

Tlayjeh, Haytham ;

Altannir, Mustafa ;

Altannir, Youssef ;

Al-Tannir, Mohamad ;

Tleyjeh, Rana ;

Hassett, Leslie ;

Kashour, Tarek .

CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (02) :215-227

[8] Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination [J].

Wall, Emma C. ;

Wu, Mary ;

Harvey, Ruth ;

Kelly, Gavin ;

Warchal, Scott ;

Sawyer, Chelsea ;

Daniels, Rodney ;

Hobson, Philip ;

Hatipoglu, Emine ;

Ngai, Yenting ;

Hussain, Saira ;

Nicod, Jerome ;

Goldstone, Robert ;

Ambrose, Karen ;

Hindmarsh, Steve ;

Beale, Rupert ;

Riddell, Andrew ;

Gamblin, Steve ;

Howell, Michael ;

Kassiotis, George ;

Libri, Vincenzo ;

Williams, Bryan ;

Swanton, Charles ;

Gandhi, Sonia ;

Bauer, David L. V. .

LANCET, 2021, 397 (10292) :2331-2333

← 1 →